Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17329408 | 0.88 | GABRA1 (0.43) | GABRA1GABRB2 | |
| SCHEMBL677034 | 0.83 | GABRA1 (0.48) | GABRA1GABRB2 | |
| SCHEMBL535990 | 0.82 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL30641415 | 0.82 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL28032475 | 0.81 | CXCR5 (0.37) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL28044146 | 0.81 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL29533387 | 0.80 | GABRA1 (0.41) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL2743774 | 0.80 | GABRA1 (0.62) | GABRA1GABRB2 | |
| SCHEMBL17160034 | 0.76 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL9839979 | 0.76 | GABRA1 (0.42) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109312027-A | Method and hydrocarbon soluble salt-like hydride catalysts for hydrogen mediated, salt-like hydride initiated anionic chain transfer polymerization and polymer distribution compositions produced therefrom | 雅宝公司 | 2019-02-05 | — | — | CN | disclosed |
| US-20080241589-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| WO-2006022731-A1 | REUSABLE FRIEDEL-CRAFTS CATALYSTS, THEIR USE, AND THEIR REGENERATION | ALBEMARLE CORPORATION (US) | 2006-03-02 | — | — | WO | disclosed |
| CN-1124253-A | Copolymer of olefin carboxylic anhydride, long chain olefin hydrocarbon and fluorine substituted hydrocarbon | HOECHST AG (DE) | 1996-06-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241589-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | OR10J3, AOC2, L1CAM | GABRA1 2874/4885GABRB2 2051/4885ALDH1A1 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.